Unidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología, México/Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Av. San Fernando No. 22, Col. Sección XVI, Tlalpan, 14080 Mexico City, Mexico.
Departamento de Medicina Genómica y Toxicología Ambiental, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, 04510 Mexico City, Mexico.
Viruses. 2018 Jan 18;10(1):45. doi: 10.3390/v10010045.
Persistent infections with High Risk Human Papillomaviruses (HR-HPVs) are the main cause of cervical cancer development. The E6 and E7 oncoproteins of HR-HPVs are derived from a polycistronic pre-mRNA transcribed from an HPV early promoter. Through alternative splicing, this pre-mRNA produces a variety of E6 spliced transcripts termed E6*. In pre-malignant lesions and HPV-related cancers, different E6/E6* transcriptional patterns have been found, although they have not been clearly associated to cancer development. Moreover, there is a controversy about the participation of E6* proteins in cancer progression. This review addresses the regulation of E6 splicing and the different functions that have been found for E6* proteins, as well as their possible role in HPV-induced carcinogenesis.
高危型人乳头瘤病毒(HR-HPV)的持续感染是宫颈癌发展的主要原因。HR-HPV 的 E6 和 E7 致癌蛋白来源于 HPV 早期启动子转录的多顺反子前 mRNA。通过选择性剪接,这种前 mRNA 产生了各种 E6 剪接转录本,称为 E6*。在癌前病变和 HPV 相关癌症中,已经发现了不同的 E6/E6转录模式,但它们与癌症的发展并没有明确关联。此外,E6蛋白在癌症进展中的作用存在争议。这篇综述讨论了 E6 剪接的调控以及为 E6*蛋白发现的不同功能,以及它们在 HPV 诱导的致癌作用中的可能作用。